全国服务咨询热线:
18501609238
18501609238
AOA体育相关的文章
Related Articles详细介绍
| 品牌 | 其他品牌 | 供货周期 | 现货 |
|---|---|---|---|
| 应用领域 | 医疗卫生,环保,食品,化工,生物产业 |
Biovisoin代理销售 1945-1
Biovisoin代理销售 1945-1
| 1945-1 | Bisindolylmaleimide I |
| 1945-5 | Bisindolylmaleimide I |
| 1946-1 | Ro 31-8220 methanesulfonate |
| 1946-5 | Ro 31-8220 methanesulfonate |
| 1947-1 | Bisindolylmaleimide I hydrochloride |
| 1947-5 | Bisindolylmaleimide I hydrochloride |
| 1948-1 | C646, p300/CBP Inhibitor |
| 1948-5 | C646, p300/CBP Inhibitor |
| 1949-250 | Compound E |
| 1949-1000 | Compound E |
| 1950-1 | Roscovitine |
| 1950-5 | Roscovitine |
| 1951-5 | TAK 165 |
| 1951-25 | TAK 165 |
| 1952-5 | Olaparib |
| 1952-25 | Olaparib |
| 1953-2 | GSK-3 Inhibitor, AR-A014418 |
| 1953-5 | GSK-3 Inhibitor, AR-A014418 |
| 1954-5 | Doramapimod |
| 1954-25 | Doramapimod |
| 1955-5 | Rosuvastatin |
| 1955-25 | Rosuvastatin |
| 1956-5 | Tigecycline |
| 1956-25 | Tigecycline |
| 1957-5 | Vinorelbine Tartrate |
| 1957-25 | Vinorelbine Tartrate |
| 1958-5 | Pixantrone maleate |
| 1958-25 | Pixantrone maleate |
| 1959-5 | Vinblastine Sulfate |
| 1959-25 | Vinblastine Sulfate |
| 1960-1 | GSK-1120212 |
| 1960-5 | GSK-1120212 |
| 1961-1 | GSK-2126458 |
| 1961-5 | GSK-2126458 |
| 1962-5 | IWP-2 |
| 1962-25 | IWP-2 |
| 1963-1 | DPP IV Inhibitor, K 579 |
| 1963-5 | DPP IV Inhibitor, K 579 |
| 1964-1 | DPP IV Inhibitor, NVP DPP 728 |
| 1964-5 | DPP IV Inhibitor, NVP DPP 728 |
| 1965-1 | PX-866 |
| 1965-5 | PX-866 |
| 1966-5 | CUDC-101 |
| 1966-25 | CUDC-101 |
| 1967-1 | StemRegenin 1 |
| 1967-5 | StemRegenin 1 |
| 1968-5 | Iniparib |
| 1968-25 | Iniparib |
| 1969-5 | CID 2745687 |
| 1969-25 | CID 2745687 |
| 1970-50 | Emetine dihydrochloride |
| 1970-250 | Emetine dihydrochloride |
| 1971-1 | GW501516 |
| 1971-5 | GW501516 |
| 1972-10 | Leflunomide |
| 1972-50 | Leflunomide |
| 1973-5 | A77 1726 |
| 1973-25 | A77 1726 |
| 1974-5 | ML130 |
| 1974-25 | ML130 |
| 1975-5 | Elastase Substrate, Fluorogenic |
| 1976-1 | SANT-2 |
| 1976-5 | SANT-2 |
| 1977-100 | Myeloperoxidase Inhibitor |
| 1977-500 | Myeloperoxidase Inhibitor |
| 1978-1 | SANT-1 |
| 1978-5 | SANT-1 |
| 1979-10 | PPARγ Antagonist, G3335 |
| 1979-25 | PPARγ Antagonist, G3335 |
| 1980-5 | Salubrinal |
| 1981-500 | MMP-9 Inhibitor |
| 1982-1 | Cathepsin G Inhibitor |
| 1983-1 | Syk Inhibitor |
| 1983-5 | Syk Inhibitor |
| 1984-250 | Tubacin |
| 1984-1000 | Tubacin |
| 1985-500 | Biotinyl-ASTD-FMK |
| 1985-1000 | Biotinyl-ASTD-FMK |
| 1986-1 | Z-FA-FMK |
| 1986-5 | Z-FA-FMK |
| 1987-50 | Itraconazole |
| 1987-100 | Itraconazole |
| 1987-500 | Itraconazole |
| 1987-1000 | Itraconazole |
| 1988-10 | Piperlonguminine |
| 1988-50 | Piperlonguminine |
| 1989-1 | EZSolution™ A83-01, Sterile-Filtered |
| 1990-1 | EZSolution™ PD-0325901, Sterile-Filtered |
| 1991-1 | EZSolution™ CHIR99021, Sterile-Filtered |
| 1992-1 | EZSolution™ SB-431542, Sterile-Filtered |
| 1993-1 | EZSolution™ Thiazovivin, Sterile-Filtered |
| 1994-1 | EZSolution™ Y-27632, Sterile-Filtered |
| 1995-5 | LDN193189 |
| 1995-25 | LDN193189 |
| 2002-5 | Gardiquimod |
| 2002-25 | Gardiquimod |
| 2003-5 | Loxoribine |
| 2003-25 | Loxoribine |
| 2004-25 | Valsartan |
| 2004-100 | Valsartan |
| 2004-500 | Valsartan |
| 2005-5 | Luteolin |
| 2005-25 | Luteolin |
| 2006-100 | Caffeic Acid |
| 2006-500 | Caffeic Acid |
| 2007-5 | Masitinib |
| 2007-25 | Masitinib |
| 2008-1 | Quizartinib |
| 2008-5 | Quizartinib |
| 2009-5 | NSC 66811 |
| 2010-5 | (R,S)-Rolipram |
| 2011-1 | RO4929097 |
| 2011-5 | RO4929097 |
| 2012-1 | Epothilone B |
| 2012-5 | Epothilone B |
| 2013-500 | K252a |
| 2013-1000 | K252a |
| 2014-5 | WP-1130 |
| 2014-25 | WP-1130 |
| 2016-5 | LDN-57444 |
| 2016-25 | LDN-57444 |
| 2017-500 | EZSolution™ SU-5402 |
| 2018-1 | ZM 447439 |
| 2018-5 | ZM 447439 |
| 2019-5 | SQ 22536 |
| 2019-25 | SQ 22536 |
| AOA体育-10 | (±)-Thalidomide |
| AOA体育-50 | (±)-Thalidomide |
| 2021-5 | NSC-687852 |
| 2021-25 | NSC-687852 |
| 2022-5 | Motesanib |
| 2022-25 | Motesanib |
| 2023-5 | Neratinib |
| 2023-25 | Neratinib |
| 2024-5 | Tandutinib |
| 2024-25 | Tandutinib |
| 2025-5 | Vatalanib Dihydrochloride |
| 2025-25 | Vatalanib Dihydrochloride |
| 2026-5 | Vatalanib, Free Base |
| 2026-25 | Vatalanib, Free Base |
| 2027-1 | BAY 58-2667 Hydrochloride |
| 2028-10 | Bilobalide |
| 2028-50 | Bilobalide |
| 2029-25 | EZSolution™ Dasatinib |
| 2030-5 | EZSolution™ Gefitinib |
| 2031-25 | EZSolution™ BAY 43-9006 |
| 2032-5 | Aclacinomycin A |
| 2032-25 | Aclacinomycin A |
| 2033-10 | MDBN |
| 2033-50 | MDBN |
| 2034-10 | Bikinin |
| 2034-50 | Bikinin |
| 2035-5 | Fatostatin |
| 2035-25 | Fatostatin |
| 2036-1 | Dodecyl-β-D-maltopyranoside |
| 2036-5 | Dodecyl-β-D-maltopyranoside |
| 2036-25 | Dodecyl-β-D-maltopyranoside |
| 2036-50 | Dodecyl-β-D-maltopyranoside |
| 2037-5 | Spautin-1 |
| 2037-25 | Spautin-1 |
| 2038-100 | Ilimaquinone |
| 2039-1 | RO-3306 |
| 2039-5 | RO-3306 |
| 2040-5 | BCl-2 GX15-070 |
| 2041-10 | WY-14643 |
| 2041-50 | WY-14643 |
| 2042-50 | RO 20-1724 |
| 2042-250 | RO 20-1724 |
| 2043-1 | Skyrin, Talaromyces sp. |
| 2044-5 | CHS-828 |
| 2044-25 | CHS-828 |
| 2045-1 | YM201636 |
| 2045-5 | YM201636 |
| 2046-5 | Sphingosine Kinase Inhibitor, SKI-I |
| 2046-25 | Sphingosine Kinase Inhibitor, SKI-I |
| 2047-5 | Sphingosine Kinase Inhibitor, SKI-II |
| 2047-25 | Sphingosine Kinase Inhibitor, SKI-II |
| 2048-100 | Erlotinib, Free Base |
| 2048-1000 | Erlotinib, Free Base |
| 2050-100 | TAME Hydrochloride |
| 2050-500 | TAME Hydrochloride |
| 2050-1000 | TAME Hydrochloride |
| 2051-10 | ODQ |
| 2051-50 | ODQ |
| 2052-1 | PKC412 |
| 2052-5 | PKC412 |
| 2053-1 | Pellitorine |
| 2053-5 | Pellitorine |
| 2054-10 | PK 11195 |
| 2054-50 | PK 11195 |
| 2055-5 | 1400W dihydrochloride |
| 2055-25 | 1400W dihydrochloride |
| 2056-10 | MnTMPyP Pentachloride |
| 2056-50 | MnTMPyP Pentachloride |
| 2057-5 | GW1929 |
| 2057-25 | GW1929 |
| 2058-10 | MnTBAP Chloride |
| 2058-50 | MnTBAP Chloride |
| 2059-10 | Leukadherin-1 |
| 2059-50 | Leukadherin-1 |
| 2060-250 | 3-Deazaneplanocin A |
| 2060-1000 | 3-Deazaneplanocin A |
| 2061-5 | YC-1 |
| 2061-25 | YC-1 |
| 2062-1 | Sirtinol |
| 2062-5 | Sirtinol |
| 2063-1 | Wnt Antagonist, C59 |
| 2063-5 | Wnt Antagonist, C59 |
| 2064-5 | Chelerythrine chloride |
| 2065-25 | FeTPPS |
| 2065-100 | FeTPPS |
| 2066-5 | Kartogenin |
| 2066-25 | Kartogenin |
| 2067-1 | TAPI-0 |
| 2068-1 | TAPI-1 |
| 2069-1 | TAPI-2 |
| 2070-1 | Bromodomain Inhibitor, (+)-JQ1 |
| 2070-5 | Bromodomain Inhibitor, (+)-JQ1 |
| 2072-5 | Piceatannol |
| 2072-25 | Piceatannol |
| 2073-5 | Pterostilbene |
| 2073-25 | Pterostilbene |
| 2074-1 | Rhapontigenin |
| 2074-5 | Rhapontigenin |
| 2075-5 | Carnosic Acid |
| 2075-25 | Carnosic Acid |
| 2076-50 | Trolox |
| 2076-250 | Trolox |
| 2077-50 | S-Adenosyl-L-methionine disulfate tosylate |
| 2077-100 | S-Adenosyl-L-methionine disulfate tosylate |
| 2077-500 | S-Adenosyl-L-methionine disulfate tosylate |
| 2078-10 | Cordycepin |
| 2078-50 | Cordycepin |
| 2081-100 | Digitonin, Water-Soluble |
| 2081-250 | Digitonin, Water-Soluble |
| 2081-1000 | Digitonin, Water-Soluble |
| 2082-1 | EZSolution™ Digitonin |
| 2083-1 | 4-Hydroxynonenal |
| 2083-5 | 4-Hydroxynonenal |
| 2084-5 | Renin Inhibitor |
| 2084-25 | Renin Inhibitor |
| 2085-5 | SIRT2 Inhibitor, B2 |
| 2086-1 | HAT Activator, CTPB |
| 2086-5 | HAT Activator, CTPB |
| 2087-100 | Depudecin |
| 2088-5 | Garcinol |
| 2088-25 | Garcinol |
| 2089-5 | ITSA-1 |
| 2089-25 | ITSA-1 |
| 2090-1 | Flavopiridol |
| 2090-5 | Flavopiridol |
| 2091-1 | EZSolution™ (+)-JQ1 |
| 2092-5 | EZSolution™ LDN193189 |
| 2093-50 | 3-Nitropropionic acid |
| 2093-250 | 3-Nitropropionic acid |
| 2094-50 | Nodularin |
| 2095-5 | T0070907 |
| 2096-5 | Nigericin sodium salt |
| 2096-25 | Nigericin sodium salt |
| 2097-25 | Sunitinib, Free base |
| 2097-100 | Sunitinib, Free base |
| 2097-1000 | Sunitinib, Free base |
| 2098-1 | Nexturastat A |
| 2099-1 | Decylubiquinone |
| 2099-10 | Decylubiquinone |
| 2112-2 | Acetic Acid (50 mM) |
| 2112-20 | Acetic Acid (50 mM) |
| 2114-100 | RIPA Buffer |
| 2114-500 | RIPA Buffer |
| 2121-100 | ATP Solution (100 mM) |
| 2122-10 | AEC |
| 2124-50 | Triton® X-100, MegaPure™ Detergent, 10% Solution |
| 2124-100 | Triton® X-100, MegaPure™ Detergent, 10% Solution |
| 2124-500 | Triton® X-100, MegaPure™ Detergent, 10% Solution |
| 2125-50 | Tween® 20, MegaPure™ Detergent, 10% Solution |
| 2125-100 | Tween® 20, MegaPure™ Detergent, 10% Solution |
| 2125-500 | Tween® 20, MegaPure™ Detergent, 10% Solution |
| 2126-50 | Tween® 80, MegaPure™ Detergent, 10% Solution |
| 2126-100 | Tween® 80, MegaPure™ Detergent, 10% Solution |
| 2126-500 | Tween® 80, MegaPure™ Detergent, 10% Solution |
| 2127-50 | NP-40 Substitute, MegaPure™ Detergent, 10% Solution |
| 2127-100 | NP-40 Substitute, MegaPure™ Detergent, 10% Solution |
| 2127-500 | NP-40 Substitute, MegaPure™ Detergent, 10% Solution |
| 2129-10 | PBS Tablets (1000 ml) |
| 2129-100 | PBS Tablets (1000 ml) |
| 2130-10 | PBS-Tween® Tablets (1000 ml) |
| 2130-100 | PBS-Tween® Tablets (1000 ml) |
| 2131-5G | NDSB-195 |
| 2131-25G | NDSB-195 |
| 2132-5G | NDSB-201 |
| 2132-25G | NDSB-201 |
| 2132-50G | NDSB-201 |
| 2133-1G | NDSB-211 |
| 2133-5G | NDSB-211 |
| 2133-25G | NDSB-211 |
| 2134-5G | NDSB-221 |
| 2134-25G | NDSB-221 |
| 2135-5G | NDSB-256 |
| 2135-25G | NDSB-256 |
| 2136-1G | ASB-16 |
| 2136-5G | ASB-16 |
| 2137-50 | Triton® X-114, MegaPure™ Detergent, 10% Solution, Sterile-Filtered |
| 2137-100 | Triton® X-114, MegaPure™ Detergent, 10% Solution, Sterile-Filtered |
| 2137-500 | Triton® X-114, MegaPure™ Detergent, 10% Solution, Sterile-Filtered |
| 2138-25 | Lapatinib, Free base |
| 2138-100 | Lapatinib, Free base |
| 2139-5 | Ruxolitinib, Free base |
| 2139-25 | Ruxolitinib, Free base |
| 2141-100 | Imatinib, Free base |
| 2141-1000 | Imatinib, Free base |
| 2142-25 | BAY 43-9006, Free base |
| 2142-100 | BAY 43-9006, Free base |
| 2144-1 | EZSolution™ MG-115 |
| 2145-1 | EZSolution™ PS-341 |
| 2146-1 | Altenusin, Penicillium sp. |
| 2146-5 | Altenusin, Penicillium sp. |
| 2147-500 | Amidepsine A, Humcola sp. |
| 2147-1000 | Amidepsine A, Humcola sp. |
| 2148-500 | Amidepsine D, Humcola sp. |
| 2148-1000 | Amidepsine D, Humcola sp. |
| 2149-250 | Andrastin A, Aspergillus fumigatus |
| 2149-1000 | Andrastin A, Aspergillus fumigatus |
| 2150-100 | 3,3'-Diindolylmethane |
| 2150-1000 | 3,3'-Diindolylmethane |
| 2151-1 | Anomalin A |
| 2152-250 | α-Galactosylceramide |
| 2152-1000 | α-Galactosylceramide |
| 2153-500 | Hyperforin. DCHA |
| 2153-1000 | Hyperforin. DCHA |
| 2154-2 | Smo Antagonist, SA1 |
| 2154-5 | Smo Antagonist, SA1 |
| 2155-2 | Smo Antagonist, SA9 |
| 2155-5 | Smo Antagonist, SA9 |
| 2156-250 | LY-333,531 hydrochloride |
| 2156-1000 | LY-333,531 hydrochloride |
| 2157-100 | Fenbendazole |
| 2157-500 | Fenbendazole |
| 2158-1G | MIF antagonist, p425 |
| 2159-2 | Smo Antagonist, SA10 |
| 2159-5 | Smo Antagonist, SA10 |
| 2160-50 | BODIPY-Cyclopamine |
| 2160-250 | BODIPY-Cyclopamine |
| 2161-1G | Thiabendazole |
| 2162-1 | AS601245 |
| 2162-5 | AS601245 |
| 2163-5 | Milrinone |
| 2163-25 | Milrinone |
| 2164-50 | KT5823 |
| 2164-250 | KT5823 |
| 2165-1 | Pluripotin |
| 2165-5 | Pluripotin |
| 2166-5 | 2-Methoxyestradiol |
| 2166-25 | 2-Methoxyestradiol |
| 2167-5 | BIBF1120 |
| 2167-25 | BIBF1120 |
| 2168-50 | Alendronate sodium |
| 2168-250 | Alendronate sodium |
| 2169-5 | Ebselen |
| 2169-25 | Ebselen |
| 2170-5 | PRIMA-1 |
| 2170-25 | PRIMA-1 |
| 2172-100 | DHEA |
| 2172-500 | DHEA |
| 2173-5 | EUK-118 |
| 2173-25 | EUK-118 |
| 2174-5 | EUK-124 |
| 2174-25 | EUK-124 |
| 2175-5 | EUK-134 |
| 2175-25 | EUK-134 |
| 2176-1 | 8-Hydroxyguanosine |
| 2176-5 | 8-Hydroxyguanosine |
| 2177-1 | 8-Hydroxy-2'-deoxyguanosine |
| 2177-5 | 8-Hydroxy-2'-deoxyguanosine |
| 2178-25 | bisBenzimide H 33258 |
| 2178-100 | bisBenzimide H 33258 |
| 2179-25 | bisBenzimide H 33342 |
| 2179-100 | bisBenzimide H 33342 |
| 2180-1 | Chetomin |
| 2181-100 | Latrunculin A |
| 2182-1 | Latrunculin B |
| 2183-1 | Ponasterone A |
| 2183-5 | Ponasterone A |
| 2184-250 | Muristerone A |
| 2184-1000 | Muristerone A |
| 2185-10 | Nocodazole |
| 2185-50 | Nocodazole |
| 2186-1 | Nullscript |
| 2186-5 | Nullscript |
| 2187-1G | Lithocholic acid |
| 2187-5G | Lithocholic acid |
| 2188-10 | Vildagliptin |
| 2188-50 | Vildagliptin |
| 2189-5 | Pyroxamide |
| 2189-25 | Pyroxamide |
| 2190-50 | Epoxomicin |
| 2190-250 | Epoxomicin |
| 2191-5 | Diprotin A |
| 2191-25 | Diprotin A |
| 2192-5 | Diprotin B |
| 2192-25 | Diprotin B |
| 2193-1 | IDE-1 |
| 2193-5 | IDE-1 |
| 2194-500 | SAG Analog (cis-isomer) |
| 2194-1000 | SAG Analog (cis-isomer) |
| 2195-10 | MDL 28170 |
| 2195-50 | MDL 28170 |
| 2196-500 | SAG Analog (trans-isomer) |
| 2196-1000 | SAG Analog (trans-isomer) |
| 2197-250 | (-)-Indolactam V |
| 2197-1000 | (-)-Indolactam V |
| 2198-10 | WST-1 |
| 2198-30 | WST-1 |
| 2199-10 | Ribavirin |
| 2199-50 | Ribavirin |
| 2200-50 | Acyclovir |
| 2200-250 | Acyclovir |
| 2201-10 | Valacyclovir Hydrochloride Hydrate |
| 2201-50 | Valacyclovir Hydrochloride Hydrate |
| 2202-50 | SBHA |
| 2202-250 | SBHA |
| 2203-1 | PFI-1 |
| 2203-5 | PFI-1 |
| 2204-5 | TCID |
| 2204-25 | TCID |
| 2205-1 | Aminopurvalanol A |
| 2205-5 | Aminopurvalanol A |
| 2206-5 | Cathepsin G Substrate, Colorimetric |
| 2206-25 | Cathepsin G Substrate, Colorimetric |
| 2207-25 | HDAC Substrate, Colorimetric |
| 2207-100 | HDAC Substrate, Colorimetric |
| 2208-50 | Compound W |
| 2208-250 | Compound W |
| 2209-100 | Doxycycline hyclate |
| 2209-500 | Doxycycline hyclate |
| 2210-250 | Atpenin A5 (Synthetic) |
| 2210-1000 | Atpenin A5 (Synthetic) |
| 2211-5 | SMI-4a |
| 2212-250 | 10Z-Hymenialdisine |
| 2212-1000 | 10Z-Hymenialdisine |
| 2213-5 | Thiocolchicine |
| 2213-25 | Thiocolchicine |
| 2214-250 | Terpendole C |
| 2214-1000 | Terpendole C |
| 2215-250 | Hepidic Acid |
| 2215-1000 | Hepidic Acid |
| 2216-5 | DMOG |
| 2216-25 | DMOG |
| 2217-5 | PX 12 |
| 2217-25 | PX 12 |
| 2218-50 | Retinoic acid |
产品咨询
电话
微信扫一扫
当前位置：
地址：上海市奉贤区金大公路8218号1幢
邮箱：yihbio@163.com
传真：021-62962298